SAN DIEGO (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Thursday reported a fourth-quarter loss of $3.1 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the San Diego-based company said it had a loss of 15 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 74 cents per share.
The drugmaker posted revenue of $38.2 million in the period.
For the year, the company reported a loss of $1.6 million, or 8 cents per share, swinging to a loss in the period. Revenue was reported as $109 million.
Ligand shares have increased 1 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $102.84, an increase of 12 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND
Keywords: Ligand Pharmaceuticals, Earnings Report